What to Know About Managing Familial Hypercholesterolemia — A multipronged approach is needed for these patients to achieve adequate cholesterol lowering ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ...

The long-running legal dispute between Amgen and Sanofi/Regeneron on two key patents covering the use of PCSK9 inhibitors to lower cholesterol has come to an end, with Sanofi emerging as the ...

Lowering cholesterol can reduce a person’s overall risk of heart disease and heart attack. Learn about lifestyle strategies and drugs that may help.